In the News
In the News
Experts see evidence of a second wave of COVID-19 building in Arizona, Texas, Florida and California—and Arizona “sticks out like a sore thumb in terms of a major problem,” says Jeffrey Morris, PhD.
An update to data from CHOP Policy Lab and DBEI shows that a cautious, incremental reopening strategy can help mitigate risk for a second wave. But some areas that have too quickly relaxed social distancing face high risk for resurgence. Read an article in The Washington Post.
Variations in how a county tallies can muddy interpretation, said Jeffrey Morris, PhD. And per Michael Levy, PhD, a contrast between rates in a high-income zip code and, say, Chester City would be glaring.
Michael Z. Levy, PhD, commented in Spanish on regional station Telemundo 62 about COVID-19 in the Philadelphia area. His message: “The first wave hit us hard; we weren't ready. Now we can prepare and get our balance for the next one.”
With COVID19 testing not available for all, “there’s no way to calculate your risk right now between households,” comments Michael Levy, PhD.
The US and France have seen far fewer transplantations with the advent of COVID-19, found a team including Peter Reese, MD, MSCE. Among the many reasons: An organ donor takes up an ICU bed and a ventilator.
Susan Ellenberg, PhD, commented on ABC’s Good Morning America about good clinical trial practice: As we race toward a COVID-19 vaccine, she feels we should not cut corners.
COVID-19 clinical trials to develop treatments will get answers faster if people collaborate, Susan Ellenberg, PhD, commented. “As some treatments show evidence of benefit, we will be moving to studies of drug combinations, and these trials will require larger sample sizes — meaning, in most cases, multicenter trials.”
Ebbing Lautenbach, MD, MPH, MSCE, commented on sudden second-week decline in some patients with COVID-19. Two and a half months into the pandemic, it’s well documented, “but we’re still not sure why it happens,” he said.
We can reopen some elements of society and ramp up our testing in parallel, writes Jeffrey Morris, PhD — using what we’ve now learned about COVID-19 to craft more targeted social distancing.
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics.